Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes

Background Recent studies suggest that lymph node ratio (LNR) has significantly better prognostic power than N-status in patients with colorectal cancer, in particular when the number of evaluated lymph nodes (LNs) was insufficient. The aim of this study was to assess the prognostic value of LNR in patients with resected synchronous colorectal liver metastases (SCLMs) and less than 12 examined LNs. Methods A prospectively maintained database of patients with resected SCLMs was queried for patients with less than 12 LNs evaluated at the time of surgery. X-tile software was used to determine the LNR cutoff value able to divide the patients in two subgroups with distinct prognosis. Overall survival (OS) and disease-free survival (DFS) rates were compared by log-rank test. A multivariate Cox regression analysis identified independent prognostic factors. Results A cutoff LNR value of 0.22 divided patients into Low-LNR group (35 patients) and High-LNR group (36 patients). Both OS and DFS rates were significantly higher in Low-LNR group than those in High-LNR group. Independent predictors of poor OS were High-LNR (HR: 2.841, 95% CI: 1.480–5.453, p value = 0.002), bilobar SCLMs (HR: 2.253, 95% CI: 1.144–4.437, p value = 0.019) and lack of adjuvant chemotherapy (HR: 2.702, 95% CI: 1.448–5.043, p value = 0.002), while the only independent predictor of poor DFS was High-LNR (HR: 2.531, 95% CI: 1.259–5.090, p value = 0.009). Conclusions LNR > 0.22 was independently associated with poor OS and DFS in patients with resected SCLMs and less than 12 evaluated LNs.

[1]  A. Ruzzenente,et al.  Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  J. Vauthey,et al.  Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. , 2020, Hepatobiliary surgery and nutrition.

[3]  B. Xing,et al.  Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases , 2019, BMC surgery.

[4]  D. Dai,et al.  Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer , 2019, Front. Oncol..

[5]  Z. Pan,et al.  Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection , 2018, Cancer management and research.

[6]  S. Katz,et al.  Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer. , 2017, Hepatobiliary surgery and nutrition.

[7]  Jan Sundquist,et al.  Patterns of metastasis in colon and rectal cancer , 2016, Scientific Reports.

[8]  L. Påhlman,et al.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.

[9]  C. Verhoef,et al.  The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  T. Ozawa,et al.  Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection , 2015, Annals of Surgical Oncology.

[11]  Shan Wang,et al.  Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined , 2014, Tumor Biology.

[12]  K. Søreide,et al.  Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  Shung-Haur Yang,et al.  The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients , 2013, World Journal of Surgery.

[14]  Jian-Wei Liu,et al.  Prognostic value of the lymph node ratio in stage III colorectal cancer , 2012, Chinese journal of cancer.

[15]  H. Friess,et al.  The Prognostic Value of Lymph Node Ratio in a Population-Based Collective of Colorectal Cancer Patients , 2010, Annals of surgery.

[16]  M. Choti,et al.  Timing of Multimodality Therapy for Resectable Synchronous Colorectal Liver Metastases: A Retrospective Multi-Institutional Analysis , 2009, Annals of Surgical Oncology.

[17]  B. Gustavsson,et al.  A study of lymph node ratio in stage IV colorectal cancer , 2008, World journal of surgical oncology.

[18]  J. Birkmeyer,et al.  Hospital lymph node examination rates and survival after resection for colon cancer. , 2007, JAMA.

[19]  M. Makuuchi,et al.  Selection criteria for simultaneous resection in patients with synchronous liver metastasis. , 2006, Archives of surgery.

[20]  P. Catalano,et al.  Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  I. Popescu,et al.  Metastatic colorectal cancer--what about the primary? , 2012, Acta chirurgica Iugoslavica.